Medigus Ltd Sponsored

Medigus Ltd. is a technology-based company, which engages in advancing innovative solutions for large-scale market applications. The firm focuses on medical-related devices and products on internet and other online-related technologies, and vehicle and wireless charging activities. It operates through the following segments: Corporate, E-Commerce, Online, and Others. The company was founded by Elazar Sonnenschein on December 9, 1999 and is headquartered in Tel Aviv, Israel.

Xylo Technologies Ltd. is a technology-based company, which engages in advancing innovative solutions for large-scale market applications. The firm focuses on medical-related devices and products on internet and other online-related technologies, and vehicle and wireless charging activities. It operates through the following segments: Corporate, E-Commerce, Online, and Others. The company was founded by Elazar Sonnenschein on December 9, 1999 and is headquartered in Tel Aviv, Israel.

Jeff Brands will develop dedicated software for managing inventory and logistics warehouses to support e- commerce businesses

Medigus: Jeff Brands to Enter the Logistic Warehouses Market in the U.S. to Support Amazon FBM Sellers E-commerce Growth

Revoltz Model One is a micro-mobility vehicle for last mile and food delivery. Revoltz Model One is a micro-mobility vehicle for last mile and food delivery.

Medigus: Revoltz Commenced Prototype Manufacturing of its Micro-mobility Vehicle

In recent pre- clinical studies, Polyrizon products showed strong potential in preventing human coronavirus 229E and Influenza Virus H1N1 from interacting with epithelial host cells and by inhibiting cells' death. In recent pre- clinical studies, Polyrizon products showed strong potential in preventing human coronavirus 229E and Influenza Virus H1N1 from interacting with epithelial host cells and by inhibiting cells' death.

Medigus: Polyrizon to Test its Product Candidate for Protection Against High Transmissible Corona Virus Delta Variant B.1.617.2

In recent pre- clinical studies, Polyrizon products showed strong potential by preventing coronavirus and Influenza Virus H1N1 from interacting with epithelial host cells and by inhibiting cells' death.

Medigus: Polyrizon Submits a Patent Application for Prevention of Pathogens such as Coronavirus and Allergens from Affecting Nasal Tissue

Gix Internet finished the first six months of 2021 with revenues of ~$ 16.4 million, Cortex Group Revenues for the first six months of 2021 amounted to ~$ 12.3 million Gix Internet finished the first six months of 2021 with revenues of ~$ 16.4 million, Cortex Group Revenues for the first six months of 2021 amounted to ~$ 12.3 million

Medigus: Gix Media to Acquire 70% of Leading Innovative Media-Tech Company Cortex Group for Approximately $11 Million

Privately held company Polyrizon Ltd, in which Medigus Ltd (NASDAQ: MDGS) owns 35.86% of share capital, has announced preclinical data for its Capture and Contain (C&C) platform technology. Related Content:  Medigus-Backed Polyrizon's COVID-19 Technology Is Effective Against Coronavirus, Preclinical Study Shows.

Medigus-Backed Polyrizon Develops Technology Potentially Effective Against Influenza Virus

Polyrizon's formulations previously demonstrated high efficacy by preventing coronavirus from interacting with epithelial host cells Polyrizon's formulations previously demonstrated high efficacy by preventing coronavirus from interacting with epithelial host cells

Medigus: Polyrizon's Innovative Technology Found Effective Against Influenza Virus H1N1 in Cell Culture Assays

The consumer products are being sold today at Walmart, Target, Staples, Kroger and more. The target company finished 2020 profitable with $8 million in revenues

Medigus: Jeffs' Brands Ltd. Signed a Non-Binding LOI to Acquire a Leading Consumer Products Brand Company

The innovative robotic system was aligned autonomously at the optimal charging position with 93% charging efficiency

Medigus: Charging Robotics Successfully Completes a Proof of Concept for its Electric Vehicle Wireless Charging Robot

OMER, Israel, July 26, 2021 (GLOBE NEWSWIRE) -- Medigus Ltd. (Nasdaq: MDGS), a technology company engaged in advanced medical solutions, innovative internet technologies and electric vehicle and charging solutions, today announced its board of directors authorized the company to take actions to promote a $2 million buyback program for the company's ADRs. The company expects to formally approve the buyback in conjunction with the approval of its financial statements for the 6 months ended June 30, 2021, and based on a financial advisor's opinion to be obtained. The company is required to file a motion seeking a court approval for the buyback program, and the effectiveness of the buyback plan, if formally approved, will be contingent upon such court's approval.

Medigus Board of Directors Decides to Promote a $2 Million Buyback Program

GameStop

Meta Materials

What do penny stocks investors need to know about trading small-caps in August? The post What Can Penny Stocks Investors Expect in August 2021?

What Can Penny Stocks Investors Expect in August 2021?

Medigus (MDGS) stock has caught the eye of investors on Friday with shares heading higher on news of pre-clinical trials doing well. The post MDGS Stock: 15 Things to Know About Medigus as the Penny Stock Soars appeared first on InvestorPlace.

MDGS Stock: 15 Things to Know About Medigus as the Penny Stock Soars

Moving Image Technologies

Xenetic Biosciences

These penny stocks shot up substantially today; worth it or not? The post 3 Penny Stocks That Exploded Today, One Up 144% appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

3 Penny Stocks That Exploded Today, One Up 144%

The stock price of Medigus (NASDAQ: MDGS) increased by over 63% during intraday trading. This is why it happened.

MDGS Stock Increases Over 63% Intraday: Why It Happened

Privately-held Polyrizon Ltd has reported preclinical data showing that its proprietary technology potentially reduces the risk of infection with Human coronavirus and may also prevent COVID-19. Medigus Ltd's (NASDAQ: MDGS) owns 33.24% of Polyrizon's share capital.

Medigus-Backed Polyrizon's COVID-19 Technology Is Effective Against Coronavirus, Preclinical Study Shows

Polyrizon's formulations demonstrated high efficacy by preventing coronavirus from interacting with epithelial host cells and by inhibiting cells' death

Medigus: Polyrizon's innovative proprietary technology found effective against coronavirus in a pre-clinical study

Medigus Will Leverage Proprietary Ecommerce Tools to Propel Online Presence in Global Market

Medigus Ltd. Signs Non-Binding LOI to Acquire Controlling Interest in B2B/B2C Electronics Wholesale Distributor

OMER, Israel, June 21, 2021 (GLOBE NEWSWIRE) -- Medigus Ltd. (Nasdaq: MDGS), a technology-based company engaged in advancing innovative solutions for large-scale market applications, announced today that Revoltz, its EV and wireless charging joint venture, operated through its wholly owned subsidiary, Charging Robotics Ltd. has successfully completed the preliminary design and functional prototype of Model One, its micromobility vehicle for last mile and food delivery.

Medigus Joint Venture, Revoltz Completes First Micromobility Vehicle Functional Prototype

American Battery Technology Company

Aqua Metals

CBAK Energy Technology Inc

Looking for EV penny stocks to buy? Check these 4 out for your watchlist The post Top EV Penny Stocks to Buy?

Top EV Penny Stocks to Buy? 4 You Need to Watch in 2021

Charging Robotics show ed its robot can be directed to find a specific spot under the vehicle and optimize its position for high-efficiency wireless charging

Medigus: Charging Robotics Ltd. Completed First Technological Milestone of its Robot for Wireless Charging of Electric Vehicles

OMER, Israel, April 12, 2021 (GLOBE NEWSWIRE) -- Medigus Ltd. (Nasdaq: MDGS), a technology company engaged in advanced medical solutions and innovative internet technologies, today announced that Polyrizon Ltd. (which Medigus owns 33.24% of its share capital), a private company engaged in developing highly differentiated biological gels for the purpose of protecting patients against biological threats and external pathogens, commenced a pre-clinical trial to examine its bio-gel efficacy to protect against coronavirus infection.

Medigus: Polyrizon Commenced a Pre-Clinical Study Testing Several Formulations of its Bio-Gel for Protection against Coronavirus

Gix Internet will consolidate its ad-tech operations under its subsidiary Linkury Ltd.

Medigus: Gix Internet Announced that its Board of Directors Resolved to Identify New Opportunities and Activities for a Merger

OMER, Israel, March 24, 2021 (GLOBE NEWSWIRE) -- Medigus Ltd. (Nasdaq: MDGS), a technology company engaged in advanced medical solutions and innovative internet technologies, clarified today that the previously announced $20 million private placement was conducted by its subsidiary, ScoutCam Inc. (OTCQB: SCTC) and not by Medigus. Medigus will hold 28% of ScoutCam following the consummation of the private placement. The investment represents a pre-money valuation of ScoutCam of approximately $34.2 million.

Medigus Clarifies its Announcement on ScoutCam's Private Placement

OMER, Israel, March 24, 2021 (GLOBE NEWSWIRE) --  Medigus Ltd. (Nasdaq: MDGS), a technology company engaged in advanced medical solutions and innovative internet technologies, announced today that ScoutCam Inc (OTCQB:SCTC), Medigus' subsidiary and a leading developer and manufacturer of customized micro visual solutions and supplementary technologies, announced a private placement of $20,000,000 from first tier Israeli institutional investors. The closing of the private placement is expected to occur by March 31, 2021. In connection with the private placement, the board of directors of ScoutCam' resolved to take steps to promote the uplisting to the Nasdaq Stock Market.

Medigus: ScoutCam Announced Private Placement of $20 Million from Institutional Investors

Global Automax, an Israeli vehicle importer, will have exclusive distribution rights in Israel and Greece

News for Medigus Ltd Sponsored Stock (MDGS)